Results

Total Results: 839 records

Showing results for "phase".

401. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
     April 01, 2011 - KQ3: Are there any identifiable changes early in the treatment phase that predict treatment outcomes? … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long-term functional … Early Results in the Treatment Phase That Predict Outcomes The literature offers almost no information … The effects of PECS teaching to Phase III on the communicative interactions between children with autism

402. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - In the final phase, a combined Key Informant group was formed, comprised of seven members from the original … shared with the combined Key Informant panel for consideration during the Key Question generation phase … Randomized phase III trial 281 patients (.4 – 49 years) 1999 – 2005 FU: median 3.8 years … Phase II treatment study 60 (ages 6 to 59 years) 9/1994 - End date not provided United States … Phase II/III Treatment Study 530 6/2006 – 4/2024 United States FU: 10 years HDCT with ASCR

403. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - The term “Dietary” is used in the key questions as they were finalized during the topic refinement phase … Then, we can talk about phases as this is (usually) a second phase after intercritical gout. … with oral ULT, indeed as cited by the AHRQ draft review, are not long enough in the non-extension phase … Moreover, remodeling of tissue urate crystal deposits, particularly in the early phase of ULT, is clearly … FACT trial with both allopurinol and febuxostat, and also in the pegloticase program trials early phase

404. Minimal Modeling Approaches to Value of Information Analysis for Health Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
     June 01, 2011 - Recently, a Phase III trial documented a statistically significant improvement in survival with a combination … Outcomes, Approach to VOI Calculations, and Data We used the published overall survival curves from the Phase … We estimated a distribution of mean costs arising out of a sample size similar to that of the Phase … Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase … Comparative effectiveness study [41) - Drug price: Drug Topics Red Book (42) - Survival curves: Phase

405. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
     October 01, 2011 - later version ES-4 Peer Reviewer #7 Executive Summary Of the 54% of children entering the rx phase … Sentences added to document that 60% entered open label titration and 46 % entered open label extension phase … statement on the preceding page that 165 “entered …the preliminary open label medication safety lead-in phase … possible explanation for the difference between clinician and parent ratings in the parallel study phase … Same page, 3rd paragraph, 4th line: need to change “theparallel phase” to “the parallel phase.”

406. CARDIOVASCULAR (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the five topics for which (1) preliminary phase III data for drugs, phase … lower-than-anticipated U.S. growth rates.66 The company had previously announced that it had initiated a phase … inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase … Aegerion Pharmaceuticals presents data from phase 3 extension study of Juxtapid (lomitapide) capsules

407. Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
     November 27, 2012 - However, the AHRQ report gives equal importance to data from telaprevir’s Phase II (PROVE1 and PROVE2 … ) trials and the Phase III (ADVANCE and ILLUMINATE) trials. … Additionally, the telaprevir Phase III trials also used an FDA labeled regimen outlined in the product … AHRQ found the Phase III trial that compared the telaprevir dosing that was ultimately approved by

408. EHC Technical Brief 32: Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-32-pharm-non-pharm-ptsd.pdf
     May 14, 2019 - This is an item of note and will be considered for possible expansion for the next phase of database … sponsors in case this table is translated into a functioning database during the future development phase … other recommendations for future expansion to our funding partners as they look forward to the next phase

409. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - Prospective cohort 6 Hematology-oncology Patients with hematologic malignancy (HM) during the acute phase … multiple myeloma (MM), myelodysplastic/ myeloproliferative syndromes (MDS/MPN) who survived the acute phase … Controls: 54 (33-66) NR Total: 33 (52.4) HM patients: 26 (58) Controls: 7 (39) NR N and S proteins, fluid-phase

410. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
     February 10, 2010 - our understanding of the literature and discussions with key informants during the topic-refinement phase … www.effectivehealthcare.ahrq.gov Published Online: April 25, 2011 Page 11 of 18 results at each phase

411. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Inter-rater agreement is calculated during the pilot phase of the selection process as part of our procedure … The need for third party adjudication was rare once the pilot phase of level 2 screening was completed … Many of the national laboratories screen for ANAs using solid phase assays.

412. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
     June 01, 2016 - Management of Infantile Hemangioma Management of Infantile Hemangioma Background Infantile hemangioma (IH) is the most common tumor of childhood and is estimated to affect about 4 to 5 percent of children, with higher prevalence in premature infants and in whites. IH tends to go through growth and involution ph…

413. PATIENTSLIKEME (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
     May 29, 2025 - amount of mouse work in retesting every available therapeutic that was -- that has gone through a phase

414. C-Diff-Infections-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
     January 01, 2014 - Cycle 1 (October 2012) One meta-analysis of two recently completed phase three trials55 showed that … Babady et 2010 Evaluation of Phase 1: 44 positive glutamate N/A sensitivity and GDH-CYT and Xpert PCR … infection and typing of the NAP1 strain at a cancer hospital stool samples from 39 patients Phase … 2012 Safety analysis A total of 728 adults 116 healthy N/A; tolerability, In this safety analysis of phase … Crook8 2012 Meta-analysis of 2 phase three RCCT n = 1164 -Fiadxomicin 200 mg twice daily for 10

415. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
     May 01, 2017 - growth factor and designed to be injected intraarticularly), which to date, have been tested only in Phase … These include the need to determine in Phase 1 trials whether high-intensity strength training, aimed … Tissuegene-C (InvossaTM) in patients with osteoarthritis: A phase II trials. … Tissuegene-C (Invossa™) in patients with osteoarthritis: A phase II trials. … TG-C), TGF-β1 transduced chondrocyte, improved clinical scores in patients with osteoarthritis: A phase

416. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists five topics for which (1) preliminary or published phase III data were … medication regimens tested in clinical trials has been implicated as a significant reason that many phase … Failure to determine these thresholds during Phase 2 is believed to be one of the main reasons for … Phase 3 failures.”30 Manufacturer and regulatory status: Proteus Digital Health, Inc., (Redwood City

417. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs and … phase II (or equivalent) data for devices and procedures were available; (2) information was compiled … more than 80 countries worldwide.17 Another competitor, the Obalon intragastric balloon, is in late-phase … July 2015, Pi-Sunyer and colleagues reported on comparative weight loss in 3,731 patients in the phase

418. S50 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s50.pdf
     October 01, 2007 - ORIGINAL ARTICLE Practice-Based Evidence Study Design for Comparative Effectiveness Research Susan D. Horn, PhD, and Julie Gassaway, RN, MS Objectives: To describe a new, rigorous, comprehensive practice- based evidence for clinical practice improvement (PBE-CPI) study methodology, and compare its features, advantag…

419. Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
     April 03, 2013 - During the Assessment phase, the patient is initially asked to identify image, negative cognition, emotion … restrictions, the following is an accurate description of the treatment: EMDR therapy is an eight phase … The first phase (initial report) has been completed and is described in the report. … In phase 1, the Committee task was to collect data from the DoD and the VA on programs and methods … The second phase (not yet completed) will focus on Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports

420. Facilitating a Deliberative Session: Transcript (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-transcript.pdf
     May 29, 2025 - When we get to the consultation phase of the model typically what’s happening is we’re asking participants … So what are we actually trying to do at the consultation phase? … on your participants’ energy level, or comfort, or understanding of where you’re going in the next phase